<!doctype html>
<html lang="en">

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">

    <link crossorigin="anonymous" href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css" integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w==" referrerpolicy="no-referrer"
        rel="stylesheet" />
    <link rel="stylesheet" href="./static/css/oxford.css">
    <link rel="stylesheet" href="./static/css/outliers.css">

    <title>Static outliers for NHS North West London CCG</title>
</head>

<body>
    <div class="bg-dark">
        <div class="container d-flex justify-content-center">
            <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
        </div>
    </div>

    <header>
        <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
            <div class="container">
                <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
            </div>
        </nav>
    </header>

    <main id="content">
        <div class="bg-oxford-50 mb-4">
            <div class="container pt-5 pb-4">
                <div class="row">
                    <div class="col-12">
                        <h1 class="display-5 fw-bold lh-1">Static outliers for NHS North West London CCG</h1>
                    </div>
                    <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
                        <p>At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                            prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in
                            prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.
                        </p>
                        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=ccg+W2U3Z">survey</a>                            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is
                            helpful, you can send short or detailed feedback.
                        </p>
                        <div class="collapse" id="explainerTextCollapse">
                            <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions
                                for each chemical in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between June 2021 and
                                December 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard
                                deviations a given practice/CCG/PCN/STP is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an
                                outlier for prescribing lower than its peers.
                            </p>
                            <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may
                                be warranted and where it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
                            </p>
                        </div>
                        <p>
                            <button id="explainerTextBtn" class="btn btn-link p-0" type="button" data-bs-toggle="collapse" data-bs-target="#explainerTextCollapse" aria-expanded="false" aria-controls="explainerTextCollapse">
                  Show more &plus;
                </button>
                        </p>
                    </div>
                </div>
            </div>
        </div>
    </main>

    <section aria-labelledby="higherHeading">
        <div class="container">
            <h2 class="pb-3" id="higherHeading">Prescribing where NHS North West London CCG is higher than most</h2>
            <button id="higherHeading-lowShowHide" class="btn btn-outline-danger-outline mb-3" type="button">Hide low numbers</button>
        </div>
        <div class="container mb-4">
            <div class="table-responsive">
                <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="low_number row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1103010P0&amp;denomIds=11.3.1&amp;selectedTab=summary">Natamycin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Antibacterials</td>
      <td>23442</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_qDUZjfcojNqqFW0rCBGotKJRowxeohYb"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_qDUZjfcojNqqFW0rCBGotKJRowxeohYb" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAALpklEQVR4nO3de8wlZWHH8e+zNwu7AYJGgmAZS6qumIBoQlLjFduGndI0gQJCZAUSTJSUqDUZjfcojNqqFW0rCBGotKJRowxeohYbJVK5BUErFzOVW3VbL7ACrrs7/WNm49mX5d3nXd/3PHP5fpInc+Zc3vM753n3vL89Z85MaJoGSZKkvVmVOoAkSRoGS4MkSYpiaZAkSVEsDZIkKYqlQZIkRbE0SJKkKJYGSZIUxdIgSZKiWBokSVIUS4MkSYpiaZAkSVEsDZIkKYqlQZIkRbE0SJKkKJYGSZIUxdIgSZKiWBokSVIUS4MkSYpiaZAkSVEsDZIkKYqlQZIkRbE0SJKkKJYGSZL2JoT1hNB0Y33qOKlYGiRJUpQ1qQPsi6yoNgMPAN+ty/zh1HkkSZqCob7T8Enga8D3s6J6WuIskiRNwlBLwwXAdcARwLVZUR2QNo4kSeMXmqZJnWGfZEW1DrgWOB74OpDXZb4tbSpJ0ii1Gz9u7dY20DS/ThknlaG+00BXEE4CbgNeAVySFVVIm0qSpPEabGkAqMv8V8Am4F7gTOBdaRNJkjReg/14YlZWVEcB1wMbgI11md+ZOJIkaUz8eAIY+DsNu9RlfgftxpGrgLcljiNJ0iiNojR0PgZsAU7Pimpj6jCSJI3NaEpDXeZbgffTPqa3J44jSdLojKY0dP4R+ClwalZUz00dRpKkMRlVaajL/BGgBALwjsRxJEkalVGVhs7HgQeBk7OiOjp1GEmSxmJ0paEu80eBC7vVdyaMIknSqIyuNHQuoT0K5l9lRXVk6jCSJI3BKEtDXeaPARd3q+ekzCJJ0liMsjR0LgN2AmdnRbU2dRhJkoZutKWhLvN7aY+CeQhwYuI4kiQN3mhLQ+eSbnlu0hSSJI3A2EvDtbQbRP5ZVlRZ4iySJA3aqEtDXebbgUtpd/bkBpGSJP0eRl0aOpcCDXBOVlRrUoeRJGmoRl8a6jL/b+CrwKFAnjiOJEmDNfrS0Nm1zwY3iJQkaR9NpTRcA/wPcEJWVIenDiNJ0hBNojTUZf5b4AraDSLPSBxHkqRBmkRp6FzZLTdnRRWSJpEkaYAmUxrqMr8duBnYCDw/cRxJkgZnMqWhc3m3PDNpCkmSBmhqpeFfge3A6VlRrUsdRpKkIZlUaajLfAvtrqWfDJyQOI4kSYMyqdLQuaJb+hGFJElLMMXScA3wC+DErKgOTh1GkqShmFxpqMv8N8C/AWuB0xLHkSRpMCZXGjp+RCFJ0hJNtTTcANwJHJcV1bNTh5EkaQgmWRrqMm+AT3arZyeMIknSYEyyNHQuB3YCZ2ZFtTZ1GEmS+m6ypaEu8weALwOHAJsSx5EkqfcmWxo6l3bLc5KmkCRpAKZeGipgC7ApK6pDU4eRJKnPJl0a6jLfRvv1y9X49UtJkhY16dLQuaxbnp0VVUiaRJKkHpt8aajL/AfAd4FnAi9MHEeSpN6afGnouEGkJEl7YWloXQ08ApySFdUBqcNIktRHlgagLvOHgE8D+wObE8eRJKmXLA2/85FueX5WVKuTJpEkqYcsDZ26zG8FrgOOBP4ibRpJkvrH0rC7D3bLNyRNIUlSD1kadlcBdwEvzorq2NRhJEnqE0vDjLrMdwL/0K2+PmUWSZL6xtLweJcDvwROy4rqsNRhJEnqC0vDAnWZbwU+DqwBXpc4jiRJvWFp2LOPAtuB12RFtX/qMJIk9YGlYQ/qMr+Pdi+RBwPnJY4jSVIvWBqe2LuBHcBbsqJ6SuowkiSlZml4AnWZ/wj4Z+BA4G2J40iSlJylYXHvAh4GXpsV1R+nDiNJUkqWhkXUZb4FuJD2mxQXJo4jSVJSloa9+zBwH3BSVlQvTB1GkqRULA17UZf5o8BbutW/z4oqpMwjSVIqloY4nwJuAY4DzkqcRZKkJCwNEbpjUpxH+xXMj2ZFdVTiSJIkzZ2lIVJd5tcDbwf2A67Oimp94kiSJM2VpWFpSuBrwHOAixJnkSRpriwNS9B9TPEq4EHgrKyozkwcSZKkubE0LFFd5j8DXgnsBP4pK6qjE0eSJGkuLA37oC7zb9Fu37A/cF1WVH+SOJIkSSvO0rDvLgDeBxwEfD0rqk2J80iStKJC0zSpMwxaVlRvBP4O2A5srsv8qsSRJEnLLYT1wNZubQNN8+uUcVKxNCyDrKg2A5cCq2kLxLvrMn84bSpJ0rKxNACWhmWTFdWJwFXABtpvV7wJuKouc59gSRo6SwNgaVhWWVE9DXg/cEZ31reB9wDfqMt8e7JgkqTfj6UBsDSsiKyoXkS786ddX8f8KfBp2mNYfM93HyRpYCwNgKVhxWRFtQY4hXZnUH9Ku70DwC+Bm4EbgZuAO4H7gf+1TEjS/GVFtQpYu8hY87z7/2u/z//L394E8Nenv+/o7z39qEeAZmZsX2yM5fXd0jAHWVE9FTiVtkS8APiDPVxtG/AA8H/AQ8DD3fJR2l+63z7BcgftL+yslV5fqqUeTnylrz+W++hjpnncRx8zzeM++phpHvcRaP/T9bg/5Hs4b7HzFxur2Yv9tj3GDz90MgAbX/9ZHl23p5fxRe1kL8ViOUdd5ucvNWCMNSvxQ7W7bi+SFwEXde9AbASeDxwLPAM4rBtZNyRJy6+h/Q/XrvHYzOltCy6bHdvXNDtWA68AWN3s+Gb388LMWE37NzV2rKPdQeCu9eW2IqVhcO80hBDuAGiaxsNTJ+Ic9IPzkJ5z0A/Ow/y4R0hJkhTF0iBJkqJYGiRJUhRLgyRJimJpkCRJUSwNkiQpyuC+cilJktLwnQZJkhTF0iBJkqJYGiRJUhRLgyRJimJpkCRJUSwNkiQpylxKQwjhpSGEO0IId4cQPhFCeNyxy0MIp4QQ7gwh3BNCeO/M+QeEEL4UQrgrhHBjCGHjStxm7Ho2B1eHELaEEO5eycfcR32ZhxDCMSGE73RZbg8h/M1KP/Y+6dE8rA8h/GcI4dYuz8UhhJU4THLv9GUOFtxfNcXXpSVpmmZFB20xuRt4Trd+NbB5wXUOBH4CHEp7XPHrgZd0l70HuKA7vQn495W4zZhHn+agW385cCxwd+rnZqrzADwTeFZ3+gDgLuCY1M/RBOdhFbBh5vTngFenfo6mNAcz93cGcOXUXpeWPHdz+OU4DviPmfU/B7644DqnAlfMrL8G+Eh3+ofAH81cdj/w5OW+zZhHn+ZgZj2b2j/OPs7DzPlfBE5M/RxNeR6AdUDFgj+eYxx9mwPgKbQF49lTe11a6pjHxxOHA/fOrP8EePoSrrPwsvu685b7NmPWpzmYsl7OQwjhSOAFwHciH8fQ9W4eQgg3AFuAh4BPxT+UwerbHHwYeCvw2FIexBTNozSEZbpOqtuMQZ/mYMp6Nw8hhIOALwDnN03z8339OQPTu3lomuY44DDgYOCl+/pzBqQ3cxBCOAHY0TTNN/fh/iZnHqXhXnZvkH9I2/Bir3PfgssOp31bablvM2Z9moMp69U8hBD2p307/JKmaT6zxMcyZL2ah12aptlK9zFR5OMYsj7NwYuB40MINfBt4IgQwm1LezgTMofPrlYDP2b3DV7OWnCdA2kne3bjlZd1l72X3Tde+dZK3GbMo09zMHN/GRP77LBP8wCsBb4CvDP18zLxeXgqcFB3+km0Je7c1M/RlOZgwX1O7nVpyXM3p1+QlwM/AO4BLusm8y+BT8xc5zTaLbjvAS5c8ItzTXfZzcBRK3GbsY+ezUEFPAhsp23/b079/ExtHmi3FN8B3DozTk79/ExwHo4BbgFuA+4APgCsSv38TGkOFmTKsDQsOjw0tiRJiuIeISVJUhRLgyRJimJpkCRJUSwNkiQpiqVBkiRFsTRIkqQolgZJkhTF0iBJkqJYGiRJUhRLgyRJimJpkCRJUSwNkiQpiqVBkiRFsTRIkqQolgZJkhTF0iBJkqJYGiRJUhRLgyRJimJpkCRJUSwNkiQpiqVBkiRFsTRIkqQolgZJkhTF0iBJkqL8P5jo0C/nrnxCAAAAAElFTkSuQmCC"></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1103010P0AAABAB&amp;denomIds=11.3.1&amp;selectedTab=summary" target="_blank">Natamycin 5% eye drops preservative free : 1</a></li></ul></td></tr><tr class="low_number row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1103010X0&amp;denomIds=11.3.1&amp;selectedTab=summary">Tobramycin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Antibacterials</td>
      <td>23442</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_qDUZjfcojNqqFW0rCBGotKJRowxeohYb"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_qDUZjfcojNqqFW0rCBGotKJRowxeohYb" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1103010X0AAAAAA&amp;denomIds=11.3.1&amp;selectedTab=summary" target="_blank">Tobramycin 3mg/ml eye drops : 1</a></li></ul></td></tr><tr class="low_number row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1104010F0&amp;denomIds=11.4.1&amp;selectedTab=summary">Clobetasone butyrate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>2</td>
      <td>Corticosteroids</td>
      <td>16935</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_aa1Eq8mJKVaNsEetVcBqLS6FtaKi6YPl"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_aa1Eq8mJKVaNsEetVcBqLS6FtaKi6YPl" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAM1ElEQVR4nO3dfaxkdX3H8fePfWh5yELAlKxAPS0VWdcEFVISibQV24Y90ppKgYJlAyQ1aa1Eq8mJKVaNsEetVcBqLS6FtaKi6YPloLVqsVViowJBnuTBnLo8VGmtlceuu3v6x/ktnb3cvffM3Zn5nZl5v5KTmTOPn/Pd2Xs/d+bMTGiaBkmSpOUckDqAJEmaDpYGSZLUiaVBkiR1YmmQJEmdWBokSVInlgZJktSJpUGSJHViaZAkSZ1YGiRJUieWBkmS1ImlQZIkdWJpkCRJnVgaJElSJ5YGSZLUiaVBkiR1YmmQJEmdWBokSVInlgZJktSJpUGSJHViaZAkSZ1YGiRJUieWBkmS1ImlQZKk5YRwMCE0cTk4dZxULA2SJKmT1akDrERWVJuBh4Gv12X+WOo8kiTNg2l9puEa4AvAt7Oiem7iLJIkzYVpLQ2XATcBzwNuzIpqXdo4kiTNvtA0TeoMK5IV1VrgRuA04ItAXpf5jrSpJEkzqd358fG4dghN80TKOKlM6zMNxILwGuB24JXAVVlRhbSpJEmaXVNbGgDqMv8fYBOwHTgfeEfaRJIkza6pfXliUFZUG4GbgUOADXWZ35s4kiRplvjyBDDlzzTsUZf5nbQ7Rx4AXJI4jiRJM2kmSkP058CjwLlZUW1IHUaSpFkzM6WhLvPHgffQbtPbEseRJGnmzExpiD4EfB84OyuqF6UOI0nSLJmp0lCX+ZNACQTgTxLHkSRppsxUaYg+AjwCnJkV1Qmpw0iSNCtmrjTUZf4UsCWuvj1hFEmSZsrMlYboKtpvwXx1VlTHpg4jSdIsmMnSUJf508BfxtWLUmaRJGlWzGRpiK4GdgMXZkW1JnUYSZKm3cyWhrrMt9N+C+aRwBmJ40iSNPVmtjREV8XD30uaQpKkGTDrpeFG2h0ify0rqixxFkmSptpMl4a6zHcCW2k/7MkdIiVJ2g8zXRqirUADXJQV1erUYSRJmlYzXxrqMv934B+B9UCeOI4kSVNr5ktDtOczG9whUpKkFZqX0nAD8B/A6VlRHZ06jCRJ02guSkNd5j8BttHuEHle4jiSJE2luSgN0cfi4easqELSJJIkTaG5KQ11md8B3AJsAE5MHEeSpKkzN6UhujYenp80hSRJU2jeSsMngJ3AuVlRrU0dRpKkaTJXpaEu80dpP1r6COD0xHEkSZoqc1Uaom3x0JcoJEkawjyWhhuA/wbOyIrq8NRhJEmaFnNXGuoy/1/gk8Aa4JzEcSRJmhpzVxoiX6KQJGlI81oa/g24Fzg5K6rjU4eRJGkazGVpqMu8Aa6JqxcmjCJJ0tSYy9IQXQvsBs7PimpN6jCSJPXd3JaGuswfBj4HHAlsShxHkqTem9vSEG2NhxclTSFJ0hSY99JQAY8Cm7KiWp86jCRJfTbXpaEu8x20b79chW+/lCRpSXNdGqKr4+GFWVGFpEkkSeqxuS8NdZnfBXwdOA44JXEcSZJ6a+5LQ+QOkZIkLcPS0LoeeBI4KyuqdanDSJLUR5YGoC7zHwOfAg4CNieOI0lSL1ka/t8V8fDirKhWJU0iSVIPWRqiusxvA24CjgVelTaNJEn9Y2nY25/FwzclTSFJUg9ZGvZWAfcBp2ZF9dLUYSRJ6hNLw4C6zHcDl8fVN6bMIklS31ganu1a4EfAOVlRHZU6jCRJfWFpWKAu88eBjwCrgT9IHEeSpN6wNCzug8BO4HVZUR2UOowkSX1gaVhEXeYP0n5K5OHA6xPHkSSpFywN+/ZOYBfw1qyonpM6jCRJqVka9qEu8+8AfwEcClySOI4kSclZGpb2DuAx4Pezonp+6jCSJKVkaVhCXeaPAlto30mxJXEcSZKSsjQs7wPAg8BrsqI6JXUYSZJSsTQsoy7zp4C3xtX3ZUUVUuaRJCkVS0M3HwduBU4GLkicRZKkJCwNHcTvpHg97VswP5gV1cbEkSRJmjhLQ0d1md8MvA04ELg+K6qDE0eSJGmiLA3DKYEvAC8ErkycRZKkibI0DCG+TPG7wCPABVlRnZ84kiRJE2NpGFJd5j8AfgfYDXw4K6oTEkeSJGkiLA0rUJf5V2j3bzgIuCkrqpcljiRJ0thZGlbuMuDdwGHAF7Oi2pQ4jyRJYxWapkmdYaplRfVHwJ8CO4HNdZlflziSJGnUQjgYeDyuHULTPJEyTiqWhhHIimozsBVYRVsg3lmX+WNpU0mSRsbSAFgaRiYrqjOA64BDaN9d8RbgurrMHbAkTTtLA2BpGKmsqJ4LvAc4L570VeBdwJfqMt+ZLJgkaf9YGgBLw1hkRfVy2g9/2vN2zO8Dn6L9Dotv+OyDJE0ZSwNgaRibrKhWA2fRfhjUr9Lu7wDwI+AW4JvAt4B7gYeA/7RMSNLkZUV1ALBmiWX1Sx6658C//es3fwvgt8999wnfOGbjk0AzsOxcapmVn++WhgnIiupngLNpS8RJwE8vcrEdwMPAfwE/Bh6Lh0/RPuh+so/DXbQP2EHjXh/WsF8nPu7Lz8p99DHTJO6jj5kmcR99zDSJ+wi0f3Q96xf5IqctdfpSyyqWceCOp7n7/WcCsOGNn+GptYv9GF/SbpYpFqNc6jK/eNiAXawex41qb/FTJK8ErozPQGwATgReCvwccFRcsrhIkkavof2Da8/y9MDxHQvOG1x2rm52rQJeCbCq2fXleHthYFlF+zu167KW9gMC96yP2lhKw9Q90xBCuBOgaRq/nnqAc9k3Z7M457JvzmZxzmXf5mU2fiKkJEnqxNIgSZI6sTRIkqROLA2SJKkTS4MkSerE0iBJkjqZurdcSpKkNHymQZIkdWJpkCRJnVgaJElSJ5YGSZLUiaVBkiR1YmmQJEmdTKQ0hBB+OYRwZwjh/hDCR0MIz/ru8hDCWSGEe0MID4QQLh04fV0I4R9CCPeFEL4ZQtgwjuuk0Je5hBBeHEL4WsxyRwjhDePe9uX0ZTYL7q8KIdw/ju3tqk9zCSEcGUL4+xDCPSGE74QQXjXObV9Oz2bz5pjl9hDC50MIR45z25eSYC6nhxBuCyHsDCG8dtgsk9SX2YQQjgkhfCmEcHfMs2Wc271fmqYZ60JbTO4HXhjXrwc2L7jMocD3gPW03yt+M/BL8bx3AZfF45uAfx7HdSa99GwuxwEviMfXAfcBL04xl77NZuD+zgM+BtzvXJ65r88DZ8Xjq4EjnE0D8HzgAeDAuF4C752jufwC8CJgG/DaYbLM8WzWAyfF42uBfwV+M9VslpzbBP5hTgb+ZWD914HPLrjM2cC2gfXXAVfE43cDPz9w3kPAEaO+ToIHbG/mski2zwJnJHtQ9mw2wHPif/zjSVsaejMX4AXAralm0fPZHEf7S+NwIAAfAt40L3MZOO0a9v7FuGyWeZ3NItmuAP4w1WyWWibx8sTRwPaB9e8BxwxxmYXnPRhPG/V1Jq1Pc3lGCOFY4CTgax23Yxz6NpsPAH8MPD3MRoxBn+ZyPPCDEMInQgi3hhC2hRAOH3qLRqc3s2ma5l7gynjeI8BG4PLhNmdkUsxlf7JMUp9m84z4/+jVwD91vc4kTaI0hBFdJtV1xqVPc2mvGMJhwN8BFzdN88OV3s4I9GY2IYTTgV1N03x5Bfc3ar2ZC+3TrqcClzZN8xKgBt67gtsZld7MJoRwBPBbtE9FHwV8F3jLCu57FHozlxVeZ5z6NJv2iiGsBT4DXN40zT0rvZ1xmkRp2M7eLetnaRtZ18s8uOC8o2mfBhr1dSatT3MhhHAQUAFXNU3z6SG3ZdT6NJtTgdNCCDXwVeB5IYTbh9uckenTXLYDdzVNc0c8/ZPAiUNsy6j1aTavAL7bNM0jTdPsAj4NvGzI7RmVFHPZnyyT1KfZEHfCvA64rWma93XIn8YEXjdaRdu0B3c2uWDBZQ6lHfTgjiO/Es+7lL13NvnKOK4z6aVnc1lDu1Pb21O/Xta32Sy4z4y0+zT0Zi60f3B8Gzgmrl8MfNzZNAC/SLuD3bq4/n6gnJe5DNzuNey9T8OyWeZ1NvG0rcBfEb9Isq/LpP5xXgHcRbtH8dVxkL8BfHTgMufQ7rX/ALBlwT/aDfG8W4CN47hOogdtL+ZC+86AXcBtA8uZzuZZmTISloa+zQV4eTztduBzwHpn88x5lwD30BarvwEOm6O5nEb7l/UTwA/j8Z/aV5Y5e8wsOhvgFKCJj5c9P4PfkHI2+1r8amxJktSJnwgpSZI6sTRIkqROLA2SJKkTS4MkSerE0iBJkjqxNEiSpE4sDZIkqRNLgyRJ6sTSIEmSOrE0SJKkTiwNkiSpE0uDJEnqxNIgSZI6sTRIkqROLA2SJKkTS4MkSerE0iBJkjqxNEiSpE4sDZIkqRNLgyRJ6sTSIEmSOrE0SJKkTiwNkiSpE0uDJEnq5P8Ao18FWJ03J+4AAAAASUVORK5CYII="></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1104010F0AAAAAA&amp;denomIds=11.4.1&amp;selectedTab=summary" target="_blank">Clobetasone 0.1% eye drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1104010F0BDAAAA&amp;denomIds=11.4.1&amp;selectedTab=summary" target="_blank">Clobet 0.1% eye drops : 1</a></li></ul></td></tr><tr class="low_number row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1310040S0&amp;denomIds=13.10.4&amp;selectedTab=summary">Phenothrin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>2</td>
      <td>Parasiticidal preparations</td>
      <td>2523</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_sQpjlNTEJNYViTrmAbAqQWMgIodwWEmo"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_sQpjlNTEJNYViTrmAbAqQWMgIodwWEmo" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1310040S0AAACAC&amp;denomIds=13.10.4&amp;selectedTab=summary" target="_blank">Phenothrin 0.5% liquid : 2</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408020T0&amp;denomIds=4.8.2&amp;selectedTab=summary">Phenytoin sodium</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>6</td>
      <td>Drugs used in status epilepticus</td>
      <td>1866</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_pBJtbYpifQBOqY1FlPA2tXyIIS6VBp1"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_pBJtbYpifQBOqY1FlPA2tXyIIS6VBp1" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408020T0AAAAAA&amp;denomIds=4.8.2&amp;selectedTab=summary" target="_blank">Phenytoin sodium 250mg/5ml solution for injection ampoules : 6</a></li></ul></td></tr><tr class="row_6">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1302010W0&amp;denomIds=13.2.1&amp;selectedTab=summary">Vitamin E</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_5_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>5</td>
      <td>Emollients</td>
      <td>87583</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_bK82tl2bjItOtZElLQ1EWMD5aRY4w9k"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_bK82tl2bjItOtZElLQ1EWMD5aRY4w9k" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_5_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1302010W0AAADAD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Vitamin E 50units/g cream : 5</a></li></ul></td></tr><tr class="low_number row_7">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0604011AD&amp;denomIds=6.4.1&amp;selectedTab=summary">Oestrogens conjugated with bazedoxifene</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_6_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Oestrogens and Hormone Replacement Therapy</td>
      <td>60923</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>10.20</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_qCiQZFKAMSa7TBFNSgvMpqBQECFoYBNg"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_qCiQZFKAMSa7TBFNSgvMpqBQECFoYBNg" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_6_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0604011ADBBAAAA&amp;denomIds=6.4.1&amp;selectedTab=summary" target="_blank">Duavive 0.45mg/20mg modified-release tablets : 1</a></li></ul></td></tr><tr class="low_number row_8">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0605010I0&amp;denomIds=6.5.1&amp;selectedTab=summary">Follitropin alfa</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_7_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>4</td>
      <td>Hypothalamic &amp; anterior pituitary hormone &amp; antioestrogens</td>
      <td>538</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>10.10</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_0pkyZmq77VQqLanLOEpR64KyoCMDiL"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_0pkyZmq77VQqLanLOEpR64KyoCMDiL" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_7_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0605010I0BDAAAR&amp;denomIds=6.5.1&amp;selectedTab=summary" target="_blank">Ovaleap 300units/0.5ml solution for injection cartridges : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0605010I0BDACAT&amp;denomIds=6.5.1&amp;selectedTab=summary" target="_blank">Ovaleap 900units/1.5ml solution for injection cartridges : 2</a></li></ul></td></tr><tr class="low_number row_9">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0801050BG&amp;denomIds=8.1.5&amp;selectedTab=summary">Vandetanib</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_8_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Other antineoplastic drugs</td>
      <td>1098</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>9.95</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_aKyGgP2joza1TREnNogpSk1Yy1JSG1a"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_aKyGgP2joza1TREnNogpSk1Yy1JSG1a" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_8_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0801050BGAAABAB&amp;denomIds=8.1.5&amp;selectedTab=summary" target="_blank">Vandetanib 300mg tablets : 1</a></li></ul></td></tr><tr class="low_number row_10">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0307000S0&amp;denomIds=3.7&amp;selectedTab=summary">Ivacaftor</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_9_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>3</td>
      <td>Mucolytics</td>
      <td>42321</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>9.38</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_BwStdmxq2jEDiUNLYb6wENTFqSiIS16"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_BwStdmxq2jEDiUNLYb6wENTFqSiIS16" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAANKklEQVR4nO3dfaxkdX3H8fdvn9x1t4igUigPR6GugLF0lawYtWCTEp3WYiSwRlNaE9HyBwStdmxq2j+EDiUNLYb6wENTFqSiIS16uqRNaaFFa7WClAXt7tIJC21SgQqFZes+nP5xfhtmh7v3/ubuzP2dOfN+JSfnnJk5M9/vzsP97JnfOROqqkKSJGkhy3IXIEmSpoOhQZIkJTE0SJKkJIYGSZKUxNAgSZKSGBokSVISQ4MkSUpiaJAkSUkMDZIkKYmhQZIkJTE0SJKkJIYGSZKUxNAgSZKSGBokSVISQ4MkSUpiaJAkSUkMDZIkKYmhQZIkJTE0SJKkJIYGSZKUxNAgSZKSGBokSVISQ4MkSQsJYS0hVHFam7ucXAwNkiQpyVSGhqJbnlZ0y5C7DkmSZslUhgZgK/BE0S03F93y53IXI0nSLJjW0PBt4BjgQ8DdRbdcn7keSZJabypDQ7/XeStwFHBtnG8puuUxeauSJKndpjI0APR7nWeAy4GvAq8Fvl50y5kd0SpJ0qRNbWgA6Pc6+4FfA+4DzgS+XHTL5XmrkiSpnaY6NAD0e53dwK8C24D3AlflrUiSpHYKVVXlrmEsim55MvBd4Ajg9H6v84PMJUmS2qI+odNzcW0dVfV8znJymfo9DQf0e50dwGepe7oyczmSJLVOa0JDdB2wE3hf0S3Pyl2MJElt0qrQEMc3fCauXuVZIyVJGp9WhYboFuAh4B3AezLXIklSa7QuNPR7nX3Ap+Nqz0MwJUkaj9aFhqgE/hF4I/WppiVJ0mFqzSGXw+JAyG8CjwGn9HudPZlLkiRNKw+5BNq7p4F+r/MtYAtwInBe5nIkSZp6rQ0N0Z/E+aVZq5AkqQXaHhr+Fvgh8PaiW27IXYwkSdOs1aEh/qDV5+KqexskSToMrQ4N0Z8DzwIfKLrla3IXI0nStGp9aOj3Os8BNwKrgIszlyNJ0tRqfWiIrgMq4JKiW67MXYwkSdNoJkJD/AXMbwDHAudnLkeSpKk0E6EhujbOHRApSdIizFJo+DvgYeCtHn4pSdLoZiY09HudCvhCXHVApCRJI5qZ0BBtBnYDHyy65U/lLkaSpGkyU6Gh3+v8GPgKsA7YlLkcSZKmykyFhuhLce5XFJIkjWAWQ8O3gK3AWxwQKUlSupkLDXFA5BfjqnsbJElKNHOhIboFB0RKkjSSmQwN/V7nf4DbcUCkJEnJZjI0RH5FIUnSCGY5NAwOiHxz7mIkSWq6mQ0NQ2eI/FjOWiRJmgYzGxqizcAu6gGRR+YuRpKkJpvp0NDvdZ6hPpJiDXBR5nIkSWq0mQ4N0efj/DeLbhmyViJJUoPNfGjo9zoPUA+KXA+ck7kcSZIaa+ZDQ/SncX5J1iokSWowQ0Pta8CTwHlFtzwudzGSJDWRoQHo9zq7gRuB5cBHMpcjSVIjGRpe9EWgAi4uuuXK3MVIktQ0hoao3+v8B7AFOA44L3M5kiQ1jqHhYNfG+Sc9/FKSpIMZGg72N8D3gTOBs/OWIklSsxgaBsTfo/jDuPrbOWuRJKlpDA0vdTvQB84tuuUZmWuRJKkxDA1D+r3OXuCP4uqnctYiSVKTGBrmdhP1yZ4uLLrla3MXI0lSExga5tDvdXYBn6P+9/lE5nIkSWoEQ8OhXQfsAj5cdMtX5y5GkqTcDA2H0O91ngKuB9YAv5W5HEmSsjM0zO9q4AXgsqJbFplrkSQpK0PDPPq9zhPU5214GdDLXI4kSVkZGhZ2NfCf1EdSnJW7GEmScjE0LKDf6zwP/E5cvabolv6bSZJmkn8A02wGvgdsBC7MXIskSVkYGhL0e539wOVx9aqiW67JWY8kSTkYGhL1e517gTuAE/D00pKkGWRoGM2nqA/B/IyDIiVJs8bQMIJ+r7MDuBRYDtxWdMtXZi5JkqQlY2gY3Y3AV4CTgOuLbhky1yNJ0pIwNIyo3+tUwEeBR4H3Ax/LW5EkSUvD0LAI/V7nGWATsJf63A1vylySJEkTZ2hYpH6v8x2gS32K6TuLbvm6zCVJkjRRhobDcw1wK/X4hnuKbnlK5nokSZoYQ8NhiCd9ugi4GTieOjisz1uVJEmTYWg4TP1eZx/wYeqjKo6jDg6n5a1KkqTxC1VV5a6hFeIPWV1HfTTFs8DHgZvi0RaSpGkWwlrgubi2jqp6Pmc5ubinYUziVxWXAFcA64AbgLuKbnli1sIkSRoT9zRMQNEtNwJ/BpwK/C/1T2vf2O91XshamCRpcdzTABgaJqbolquB36P+vYplwNPUex8+3+91+hlLkySNytAAGBomruiWG6iDw/uBFUAFbAHuAv4B2Bq/2pAkNZWhATA0LJmiWx4HXEx9CuqfHrjqSeBe4GFgG7A9Tk8aJqZDHAS7cmBaMcc6wH7q0FgNLQ+v7wf2UZ9xdE+c9gL7HFgrjVf8/aCVC0zVhscfWX3HrZ+8H2DTpivf+M8nvWkXL75vh+f7ePG9uwfY05b3rqFhiRXdchXwduBs4BxgI/WLcth+4CnqUPEU8Dzwf8DuOB9c3k39RwUO/kM06gQQhuZzXZY6X+pt57psGQf/ET/U8kLXzXf5Ug4oPhAg9hzmcsptD3wAsoTz+Sz043DzXT9r207yvie97YqBafnQesplCwWAVUPryxeoCYA1P9nNI9ecD8Cpl3+NF1atTtls0H6GggQvfc8t9vK91EElxIl+r/OJUQtMsWLhm2ic+r3OT4C740TRLdcCG4DXAz8LnAKcDLwaeFWcqxmG//e/i7Q39YFAF6gDRphjeXB9GS9+CM4XaNYMLPtrq9L8Kg5+X+5m7vfvXBMrqn0rgXcBLK/23RPvc/h9O/j+Xeg/HC9nsv/pmEhomLo9DSGErQBVVZ2eu5ZJmpU+wV7baFb6BHttq1nqdRSep0GSJCUxNEiSpCSGBkmSlMTQIEmSkhgaJElSEkODJElKMnWHXEqSpDzc0yBJkpIYGiRJUhJDgyRJSmJokCRJSQwNkiQpiaFBkiQlWZLQEEI4O4SwNYSwPYRwQwjhJb9fHkK4IITw7yGEHSGEKwYuPyKE8PUQwrYQwndDCKdOYpuW9np7COFHIYTtbe0zhHBGCOG+WMtDIYRLW9zr2hDCv4QQHoj1fCmEMNaft29Kr0OPV7b5NRyvq+LzemA6uqV9HhNC+KsQwg9CCD8MIfzyuPpsUq+h/lwafD6fDiFcM85es6mqaqITdTDZDpwW128HLhq6zSuAx4BjqX9z/JvAL8TrPgtcGZffA/z9JLZpW69x/V3ABmB7i5/T1wPr4/IRwDbgjJb2ugxYN7B8B/Drbex14PE+CGxu82s4ru8dZ38N7vMu4IK4vAI4uq29Dj3uNuBtk3iOl3qa/APARuDegfVzgTuHbnMhcPPA+keBa+PyI8DrBq57Ajh63Nu0rdeB9YLxf+A2rs+By+8EfqXtvQKrgJKhD8U29Qq8ivoD+g1tfw0zudDQmD6B9cD9k+izab3OUddYX785p6X4euJ4YOfA+mPACSPcZvi6x+Nl495mHJrU6yQ1ss8QwsnAW4D7EvtI0bheQwjfBn4EPAvcmt7KgprW6x8DvwvsHqWJRE3rdVkI4TshhH8NIXx8tFbm1aQ+3wD8dwjhthDC/SGEm0MIR43c0aE1qddBHwJuSepgCixFaAhjuk2ubcZ9/02se1SN6zOEcCTwl8BlVVU9vdj7meuux3SbcWwDQFVVG4GfAY4Czl7s/cyhMb2GEN4N7Kuq6u5FPF7SQ4zpNuPYBuCkqqrOBH4JeF8I4QOLvJ/F1LNUfa4A3glcUVXVzwN94OpF3M/h1LTUn0srgAswNIxkJwenvROp01jqbR4fuu546l1A495mHJrU6yQ1qs8Qwsupd9VfX1XVV0fsZSGN6vWAqqqeI34Vk9hHiib1+k7gF0MIfeCfgJNCCA+O1s68mtQrVVXtjPOnqPcevW2kbg6tSX3uBB6uquqhePlfAG8eoZeFNKnXA84FHq2qauwDebOZ9PcfwHLgUQ4enPIbQ7d5BfUTMzjQ5Jx43RUcPNDknkls07ZeBx6vYPzfBzemT2Al9eCq35+B1+9rgCPj8suog9LFbex1xl7DrwRWx+XVwF8DH2lhn8uAfwNOiOuXAbe28TkdeLzbgEvG+drNPS3Ng9Sj+B8GdgA3xX/49wI3DNxmE/UI0x3AHww9yd+I130POH0S27S01xL4L2AvdSL+dNv6pB5dvw94YGA6v43PKXAGcD/wILCVetfusjb2OlRTwQQGkjWlV+As6j+m34/P61XjfF6b0me87h3xsgeBLcCxbXxO43XrgB8zxiNEmjD509iSJCmJZ4SUJElJDA2SJCmJoUGSJCUxNEiSpCSGBkmSlMTQIEmSkhgaJElSEkODJElKYmiQJElJDA2SJCmJoUGSJCUxNEiSpCSGBkmSlMTQIEmSkhgaJElSEkODJElKYmiQJElJDA2SJCmJoUGSJCUxNEiSpCSGBkmSlMTQIEmSkhgaJElSEkODJElK8v/ii5sgIo44AwAAAABJRU5ErkJggg=="></div></div></div></div></td>
    </tr>
    <tr id="table_high_9_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0307000S0AAAAAA&amp;denomIds=3.7&amp;selectedTab=summary" target="_blank">Ivacaftor 150mg tablets : 3</a></li></ul></td></tr><tr class="low_number row_11">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0205010V0&amp;denomIds=2.5.1&amp;selectedTab=summary">Iloprost</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_10_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>2</td>
      <td>Vasodilator antihypertensive drugs</td>
      <td>6551</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>8.99</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_hdLGP45tBYtdPKVPqVJN46q4xjQ2xrbg"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_hdLGP45tBYtdPKVPqVJN46q4xjQ2xrbg" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_high_10_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0205010V0AAACAC&amp;denomIds=2.5.1&amp;selectedTab=summary" target="_blank">Iloprost 10micrograms/1ml nebuliser liquid ampoules : 2</a></li></ul></td></tr></tbody></table>
            </div>
        </div>
    </section>

    <section aria-labelledby="lowerHeading">
        <div class="container">
            <h2 class="pb-3" id="lowerHeading">Prescribing where NHS North West London CCG is lower than most</h2>
            <button id="lowerHeading-lowShowHide" class="btn btn-outline-danger-outline mb-3" type="button">Hide low numbers</button>
        </div>
        <div class="container mb-4">
            <div class="table-responsive">
                <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr class="row_1">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0&amp;denomIds=3.1.3&amp;selectedTab=summary">Theophylline</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>8074</td>
      <td>Theophylline</td>
      <td>10400</td>
      <td>0.78</td>
      <td>0.94</td>
      <td>0.04</td>
      <td>-3.84</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_4hLU41IGOSZRUTkIKoiJCy4nhUqIAgmo"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_4hLU41IGOSZRUTkIKoiJCy4nhUqIAgmo" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0AAAMAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 200mg modified-release tablets : 210</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0AAAPAP&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 300mg modified-release tablets : 70</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0AAARAR&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 400mg modified-release tablets : 39</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0AABKBK&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 50mg/5ml oral solution : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0BDAFAN&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Nuelin SA 250 tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0BHACAD&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Slo-Phyllin 250mg capsules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0BKAAAR&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 400mg tablets : 787</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0BKABAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 200mg tablets : 5668</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0301030S0BKACAP&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 300mg tablets : 1286</a></li></ul></td></tr><tr class="row_2">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0&amp;denomIds=14.4&amp;selectedTab=summary">Influenza</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>247760</td>
      <td>Vaccines and antisera</td>
      <td>265154</td>
      <td>0.93</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-3.16</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_ImpUkFLBK6gcVESQBBcRL2VUPF4IYoxG"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_ImpUkFLBK6gcVESQBBcRL2VUPF4IYoxG" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0AAAMAM&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Adjuvanted trivalent flu vacc (SA, inact) inj 0.5ml pfs : 3873</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0AAANAN&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Adjuvanted quadrivalent flu vacc (SA, inact) inj 0.5ml pfs : 488</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0BCADAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Influvac sub-unit Tetra vacc inj 0.5ml pre-filled syringes : 19967</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0BUAAAK&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Fluarix Tetra vacc inj 0.5ml pre-filled syringes : 27</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0BWAAAK&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Quadrivalent Flu/Vac/Split inj 0.5ml pfs : 28687</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0BXAAAM&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Fluad vacc inj 0.5ml pre-filled syringes : 28915</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0BYAAAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Influenza Tetra MYL vacc inj 0.5ml pre-filled syringes : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0BZAAAF&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Flucelvax Tetra vacc inj 0.5ml pre-filled syringes : 72213</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0CCAAAN&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Fluad Tetra vaccine inj 0.5ml pre-filled syringes : 90284</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1404000H0CEAAAP&amp;denomIds=14.4&amp;selectedTab=summary" target="_blank">Supemtek Quadrivalent vaccine (recombinant) inj 0.5ml pfs : 3301</a></li></ul></td></tr><tr class="row_3">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0&amp;denomIds=4.8.1&amp;selectedTab=summary">Gabapentin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>60608</td>
      <td>Control of epilepsy</td>
      <td>484211</td>
      <td>0.13</td>
      <td>0.25</td>
      <td>0.04</td>
      <td>-2.84</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_FyqoHCsiiMe6uqviWboqKIK33G7w4ihM"><img width="250" class="h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAURElEQVR4nO3deZwcZZ3H8c8TgqDhCPctBahREAkqu67XC3mhqIU3XrseKIr3gYiWrsp6FyqoHCsiiMe6uqviWboqKIK33G7w4ihMADEJCWcMkNT+8TyzmQw5amZ6prp7Pu/Xq17dU92d/FKp7vn2U88RmqZBkiRpY2Z1XYAkSRoMhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUyuCFhhDmEEKTtjldlyNJ0kwxeKFBkiR1YnbXBUjqH1lRbQLsDuwJbDNmmwtsCmxC/MIxK92/G7hzzHYbsCRti9Pt0rrMV03jP0dSj4WmabquYXziJYnb009b0DR3dFmONIiyopoDHAg8AtgX2BvYixgWpurLRAPcCCwcs10DXAVcU5f5iin6uyX1gKFBGnJZUQVgH+CJwKOARwIPZt2XJ/9K/CV+HbAUWDZqWw6sBFYDq9LtamLIuN+obQ6wFbB92nZI247ALsTWifVZRAwQfwKuBH6fbq+vy3zAPqyk4WNokIZQVlRzgUOAJ6VtrzFPWQhcnLbLgauBui7zO6e4rtnAzsAeo7a9gQekLWPdYeY2YEGq9bK0/a4uc9//0jQyNEhDIiuqrYBnAi8gtiqMvsxwCfBD4ALg4rrM/zb9FW5cVlT3IQaHecTLJiPbQ4gtGKM1wJ+Bi4DfpO0yL3FIU8fQIA2wrKg2Aw4HXgjkwObpocVARQwK59ZlvribCnsjK6pZxDBxADB/1O2eY556D3AF8CvgZ8CFdZkvmr5KpeFmaJAGUFZUewKvBl5B7DcAcCtwDvBl4Md1md/TUXnTJiuqbYl9NP5h1LbTmKddRwoQwLnEDpcD9sEn9QdDgzQg0rftQ4HXEVsXZhE7JH4b+CLw/brM/95dhd1LnT73AB4NPA54LLA/EEY9rSaGh3OJ4WqgW2Gk6WRokPpc6jz4AuCdxGv7ADcBnwE+bfP7hqVOoY8GDib29Zg/6uGG2Bfiu8B3gCtshZDWz9Ag9anUX+GlwNuJIwwAfgGcApxTl/ldXdU2yLKi2oE4suRQ4DBiy8SIhcQA8Q3gJzPhEo80HoYGqc+ksPAq4G3Abmn3D4EP1mV+QWeFDaF0OWN/4uWew4nzWIxcylhC7CPyVeB8A4RkaJD6Ruqz8M/AB1gzKuBbxLDw284Km0FSK8ThwBHE+S1Ghq0uIYaHzwO/8RKGZipDg9Sx9G33MKAkDiWEeH39XXWZX9FZYTNcGpnxDOB5xEsZIwHiD8Tw8MW6zK/vqDypE4YGqUNZUc0HTiReYwf4JfD2uswv7K4qjZUV1XbEzqgvBQ5KuxviZaNPA9/x8oVmAkOD1IH0S+j9xL4Ls4jfXt8BfMum7/6WFdW+xPDwYuJaGgDXE0ezfKYu8xu6qk2aaoYGaRqlpaePJvZb2Ja4ENR7gNP9pjpY0lDYpwCvAZ5M7EC5itgP5ZPE2SgH7ANW2jBDgzRNsqJ6NHAacZ6ABjiD2G9hSaeFadKyotqb2Gr0ctbM0HkxcBLw1brM7+6qNqmXDA3SFMuKahtiJ8ej066fA2+oy/zS7qrSVEjDZZ8PvIU1nVqvB04GzqjLfHlXtUm9YGiQpkgaFfF84BPE9RCWAMcSe90P2BtP45H+7w8mhofD0+7bgH8HPl6X+U0dlSZNiqFBmgJZUe1F/AXx5LTrbOBtXoqYebKimkcMD0cC9wH+DnwW+Ghd5nV3lUnjZ2iQeihN0PQa4CPA/YA/Aq+uy/z8LutS97Ki2hU4hnh+zCF2mvwP4AN1mV/VZW1SW4YGqUdS68Jnic3S9wAfAj5Ul/nKLutSf0mTRr0BeCNxBM0q4HPE8FB3V5m0cYYGaZLS9etXAR8jfoP8HfBSOzpqQ7Ki2hJ4PXAcsA0xaJ5FnDZ8YZe1SetjaJAmISuqPYEzidMMrwI+DLzfFSjVVlZUWxNbHY4FtgbuIk4U9WGnqVa/MTRIE5BaF44ijsPfEriS2LpwUaeFaWClobnHAG8mnlMrgdOBsi7zv3ZZmzTC0CCNU1ZUuxNbFw4DVhM7Pf6bfRfUC2mK8WOJrQ9zgBXEkTgn1GW+uMvaJEOD1FJqXXgpcd6FrYnrRRxZl/mvOy1MQykt030csd/DfYmfeycBJ9VlfkuXtWnmMjRILaThcmcAOXEK6BOB99RlvqLTwjT0sqLaGSiIQzXvA9xMnGH0tLrM7+yyNs08hgZpA1Lrwr8ApwBzgT8TWxd+0WlhmnGyoro/cXGzlxFXRr2RuFLqWXa81XQxNEjrkb7hnQ48g9i68AniAlN+u1Nn0gyT7yVOUQ5wLXA88J91ma/qrDDNCIYGaYzUuvAC4FTi5DtXAy+ry/zCTguTRsmKaj5xifU87boSeBfwTdc20VQxNEijZEW1I/Ap4Nlp1ynAO+oy9zxTX8qK6jHE2Ucfn3ZdBLwTONfwoF4zNEhJVlTPJQ5t2x6oia0L53dZk9RGah17IjE8PCLtPh/4V/vfqJcMDZrxsqLanngpYuQa8aeIK1Levv5XSf0nhYdnEy9bPDjt/i6xL87lnRWmoWFo0IyWFdWziJ0ddwT+AhxVl/m53VYlTU5WVJsALyJ2mNwz7f4KcHxd5n/qrDANPEODZqS00uDJxOGUEOf6f2td5rd2V5XUW1lRbQa8Ang3sBNxfZSzgfe5KJYmwtCgGScrqqcRJ2raGbie2Lrwg26rkqZOVlRziDNLvp24ouZdxP47ZV3mN3VZmwaLoUEzRmpdOIk4FTTEb1xvqct8eXdVSdMnK6q5xHUtjmHNuhafAj7qolhqw9CgoZc6hx1BHD65E3EmvVfWZV51WpjUkTS0uABeTVzXYgWxb89HDA/aEEODhlpWVLsBpxFndQT4LLHvwrLuqpL6Q5r19K3Aa4nh4e/Ap4krat7YZW3qT4YGDaWsqGYBryQuW70VcA1wdF3m53VamNSHsqLaiTXh4X7ASmK/nxPqMr++y9rUXwwNGjpZUT2IOBri8cBqYj+G410zQtqwdNniWOB1xD4PK4nvpRPqMl/UZW3qD4YGDY2sqDYlfls6HtgMuJw4MuLiTguTBkya8OxY4oiLLYijLb5A7DDpPA8zmKFBQyErqkcCZwIHEL8dvRf4WF3md3damDTAUng4hhgetiKu9vp1YsvDRV3Wpm4YGjTQsqLaEvg34M3ALOAC4sgIvw1JPZIV1dbEkRbHEEcgAZwHlMB5Low1cxgaNJDSMMrnAycCuwK3Am8DPlOX+eoua5OGVVZUmxPnOTkO2CftvoQYHs6py3xVV7VpehgaNHCyotqXuMDUE9KuLwHHOURMmh5pbYvnEOd6ODDtvgr4KPCFusz/3lVtmlqGBg2M1ET6LuKliNnAAuB1dZn/tNPCpBkqtfgdSgwPh6TdfyPOMnm6E0UNH0OD+l5WVLOJi+68D9iB+P9/PHCKHR2l/pAV1UHES4TPJvYvuhv4MvDJuswv6bI29Y6hQX0tK6rDiP0W9iP23P4c8K66zG/osi5J65YVVUac5+GVwNZp9wXAJ4Bv2+9hsBka1JeyonoYsXPVU9Ku84mLS13aWVGSWsuKagtip8k3AQ9Mu2viGjBn1WV+S0elaRIMDeorWVE9kDjHwguAQOxc9VbiN5QBO1klpSndn0Lsi3Ro2n07sdXwU3WZX9lRaZoAQ4P6QlZUewDvBl4ObALcBHwAOKMu87u6rE1Sb2RF9VDgjcCLgc3T7p8RF8n6el3mK7qqTe0YGtSprKjuT2xJOJo49fMy4ATg1LrM/b+VhlCaafJlxPf9A9LuZcDniV8Uft9VbdowQ4M6kRXVPODtxG8cs4E7gI8DJ9ZlvrzL2iRNj3Tp4gnAq4BnET8LIHacPIPY+uCcD33E0KBplRXVw4ljuo8g9llYDpwMnFyX+dIua5PUnbQ895HE1oe90+6lxNaHM2196A+GBk25tPrks4A3AI9Nu28iLll9el3mt3ZVm6T+klofDiG2PjyTNa0PvyWutPllv2B0x9CgKZMV1Q7EsdqvBXZLu/8EfBI4205PkjYkK6qdia0PRwLz0u67gYoYIL7v5YvpZWhQT6U56Z9EfJM/E7hPeuh7xPHZP3RBKUnjkaarPgh4CfBCYNv00K3AN4GvAOc6Q+zUMzSoJ7KiehCxN/RLiKtOAtxCvB55al3mf+6qNknDIyuqzYCcGB4OZ83QzZuBrwPnAD92qPbUMDRowlJQeA6xU+PD0+4G+BFwNvBNmw4lTZWsqLYEnk6cDO4wYNP00K3ESxjfIF7CuH3df4LGy9Cg1lIT4cOIb9Ij0v0RfwS+SFwWd2EH5UmawbKi2gZ4BrHT9ZNY0wKxkjgN/feIAcJWz0kwNGiDsqLajjj165OJSX6XUQ8vAL6WtgVO8yypH2RFNYf4efUs4iWMuaMevhr4PvAD4ELXwBgfQ4PWkhXVjsRhkY8FHgc8gjifAsBq4FfEN9zXHTctqd9lRTUbeBTwVOIaGPNHPbwauBj4Sdp+5qWMDTM0zGApjT+M2B/hEcBjgAeNedoiYiL/H+C8usyXTWuRktRDWVHtQmw5PYQ4G+Vuox5eBVwB/HLUdo2tqGsYGmaAlLT3AR6Stv2IQWEeMGvM0/9AXEBmZPMNI2kopX5aDySGhycAj2ftS7AAi4mtEZcAl6bba2fq56KhYUhkRXVfIAP2Ik7BOnL7IOKbYtN1vGwh8Q0w8mb4VV3mi6ejXknqNylE7AH806jtQO79+bkc+B1wJbFv14J0/6ZhDxOGhj6XFdXmxOS7C3H+g9Hb6H1z1/dnAH8Dfp+2PxBP7kvrMl8ydZVL0uBL80KMtM4emG4PAO67jqffQuxoua7t+rrMV01HzVPJ0DBN0nzqc4HtiLOZbdfy/pYt/vg7gRuA64BrgGtH3V7tPO2S1Dtp5tu9iWFi33S7H7Fld11hAuAu0mcy8fP5L8TW3kVpu2EQJqQyNExASp7bAduPuh25v74AsA337j+wMbcAS4iBYGS7cR0/3zbsTWKS1O/S5Y2diX3I1rVtv4GXN8SF/BaxdphYxJrP/c4/72d8aBgTANYVAtZ1f4tx/jUriEu8LiVOdbp0PT+Pvr+sLvN7JvFPkyT1kayotiK2UOwD7J62PUbd3401q3quzx2sHSLWdXvDVK0ePFShYZoCwHLiL/UlaRt7/15BwNUcJUkbky5j78jaQWJ31u7Xtgux5XqD6jIPG3vORPRtaFhfANj2juW7XHLqi94NsP+b/+vc2zabM5fJBYB1/eJf3/2bXUVNktSlNFpuZ9buEL/WbV3mD52Kv3tjzSCTlq7xbMGaa/vbjro/7haAFZtu/v/37wmbHDrqoeXAVbQPATfb/C9JGjSp9fratE2rKQ0NWVHdRAwH4/17lrEmAKz1y37LlXfcBpwKMG/JdY+8bNd5CzEASJI05ab08kRWVCtZ+xr/zWPur+8SwPoDQB+MnpAkaSaa6ssTmzsUUJKk4dC3HSHXy5YGSZI6MXihYQiEEBYANE2zX9e1zDQe+255/Lvjse/OMB378c5QKEmSZihDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxSGXkiSpFVsaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoaHHQggHhxAWhBCuCiGcGULYZB3P+e8QwuIQwlVj9h8ZQlgaQrgsbadNX+WDb2PHPoQwP4Tw8/Sc/w0hvHHUY7NDCGen1y4IITxu+v8Fg22Sx99zfxJaHPs5IYTfpGO7IIRwRghhdnrMc38SJnnsB+68NzT0UAhhFnAm8NymaR4AbAW8aB1PPR04bD1/zDeappmfttdNUalDp+WxvxN4eVqe9tHAG0II89NjRwKbpde+EDgrhBCmpfgh0IPjD577E9Ly2K8ADmmaZj6wP7D9qOccief+hPTg2MOAnfeGht46CLihaZor089nAc8Z+6SmaX4M3Dydhc0AGz32TdP8qWmaP6b7twK/B/ZIDz+H+OanaZorgKXAgdNQ97CY7PHXxLU59qubprk9/Tgb2AwYmdnPc3/iJnvsB46hobd2BxaO+vkvjP9D8WkhhMtDCD8MIRzUu9KG3riOfQhhH+CRwM8n8nrdy2SPP3juT1TrYx9C+DWwGLgV+NJ4X697meyxhwE77w0NvTXZJr3vAlnTNAcAHwS+EULYYvJlzQitj30IYS7wTeBNTdOMtPjYHDs5kz3+nvsT1/rYN03zj8BuwLbAweN9ve5lssd+4M57Q0NvLWTtlHl/YFHbFzdNs6RpmhXp/k/Ta+f1tMLh1erYhxDuB1TAZ5qm+ep4X6/1mtTx99yflHGdu6mp/NvA0ybyeq1lUsd+EM97Q0NvXQTsHkLYN/18FHBO2xeHEHYddX8/IAOu6WWBQ2yjxz6EsGna96OmaU4e8/pzgFek5z0M2AG4ZEorHi6TOv6e+5PS5tjvmFp4CCFsBjwVWJAe9tyfuEkd+0E87w0NPdQ0zSrim+9rIYSrgduBL4YQnh5COHPkeSGECvglkIUQFoUQ3pEeen0aknMZ8DngyKZplk3vv2IwtTz2zwOeCDxz1BCnI9JjnwPuDnEY7FeAoxqXgG2tB8ffc3+CWh77XYGfhBCuIAaCK0mdH/Hcn7AeHPuBO+9dGluSJLViS4MkSWrF0CBJkloxNEiSpFYMDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxdAgSZJaMTRIkqRWDA2SJKkVQ4MkSWrF0CBJkloxNEiSpFYMDZIkqRVDgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxdAgSZJaMTRIkqRWDA2SJKmV/wNiw6jlfp2leAAAAABJRU5ErkJggg=="></button><div class="modal fade" id="plot_FyqoHCsiiMe6uqviWboqKIK33G7w4ihM" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0AAAAAA&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 100mg capsules : 18684</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0AAABAB&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 300mg capsules : 33036</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0AAACAC&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 400mg capsules : 3125</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0AAAGAG&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 100mg/5ml oral liquid : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0AAAJAJ&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 600mg tablets : 4826</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0AAAKAK&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 800mg tablets : 212</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0AAAPAP&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 300mg/5ml oral liquid : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0AABGBG&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 50mg/ml oral solution sugar free : 597</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0AABHBH&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Gabapentin 400mg/5ml oral suspension : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0BBAAAA&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Neurontin 100mg capsules : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0BBABAB&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Neurontin 300mg capsules : 57</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0BBACAC&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Neurontin 400mg capsules : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0408010G0BBADAJ&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Neurontin 600mg tablets : 19</a></li></ul></td></tr><tr class="row_4">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0501090R0&amp;denomIds=5.1.9&amp;selectedTab=summary">Rifampicin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>285</td>
      <td>Antituberculosis drugs</td>
      <td>1571</td>
      <td>0.18</td>
      <td>0.73</td>
      <td>0.21</td>
      <td>-2.58</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_hXGcUU85uCvHgKMOm6DHkcdy3HEBRVl"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_hXGcUU85uCvHgKMOm6DHkcdy3HEBRVl" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0501090R0AAAAAA&amp;denomIds=5.1.9&amp;selectedTab=summary" target="_blank">Rifampicin 150mg capsules : 24</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0501090R0AAABAB&amp;denomIds=5.1.9&amp;selectedTab=summary" target="_blank">Rifampicin 300mg capsules : 89</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0501090R0AAAFAF&amp;denomIds=5.1.9&amp;selectedTab=summary" target="_blank">Rifampicin 100mg/5ml oral suspension : 22</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0501090R0BBAAAA&amp;denomIds=5.1.9&amp;selectedTab=summary" target="_blank">Rifadin 150mg capsules : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0501090R0BBABAB&amp;denomIds=5.1.9&amp;selectedTab=summary" target="_blank">Rifadin 300mg capsules : 129</a></li></ul></td></tr><tr class="row_5">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0&amp;denomIds=4.7.2&amp;selectedTab=summary">Morphine sulfate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>24965</td>
      <td>Opioid analgesics</td>
      <td>196888</td>
      <td>0.13</td>
      <td>0.22</td>
      <td>0.04</td>
      <td>-2.58</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_XcQLHG9F8QJ0XfAAFLnaARQQFRUzoRN"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_XcQLHG9F8QJ0XfAAFLnaARQQFRUzoRN" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAA4A4&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 1mg/1ml solution for injection ampoules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAA6A6&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 20mg/ml oral solution sugar free : 42</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/1ml solution for injection ampoules : 1666</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAACAC&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 15mg/1ml solution for injection ampoules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAADAD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 30mg/1ml solution for injection ampoules : 29</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAAFAF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 20mg/1ml solution for injection ampoules : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAAHAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 100mg modified-release tablets : 43</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAAIAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release tablets : 96</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAAKAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release tablets : 939</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAALAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release tablets : 517</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAAMAM&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 60mg/2ml solution for injection ampoules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AACDCD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg tablets : 520</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AACECE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 20mg tablets : 208</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AACFCF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 15mg modified-release tablets : 435</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AACGCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 5mg modified-release tablets : 784</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AACNCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/5ml oral solution : 5517</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AACPCP&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release granules sachets sugar free : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AACVCV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 20mg modified-release granules sachets sugar free : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AADRDR&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 50mg tablets : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AADVDV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 120mg modified-release capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAEBEB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 100mg modified-release capsules : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAEFEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release capsules : 264</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAEGEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release capsules : 176</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAEHEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release capsules : 82</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAEIEI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 200mg modified-release capsules : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAENEN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 50mg/50ml solution for infusion vials : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAFZFZ&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 5mg/5ml solution for injection ampoules : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0AAGAGA&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/10ml solution for injection ampoules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BBAAAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 10mg tablets : 1640</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BBABAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 30mg tablets : 819</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BBACAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 60mg tablets : 412</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BBADAH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 100mg tablets : 93</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BBAEAG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 200mg tablets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BBAFCV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus suspension 20mg granules sachets : 18</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BBAGCP&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus suspension 30mg granules sachets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BBAKCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 5mg tablets : 953</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BBALCF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 15mg tablets : 570</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BCABA6&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Oramorph 20mg/ml concentrated oral solution : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BCAGCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Oramorph 10mg/5ml oral solution : 6121</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BHACCD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 10mg tablets : 537</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BHADCE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 20mg tablets : 245</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BHAFDR&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 50mg tablets : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BIAAEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 30mg capsules : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BIABEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 60mg capsules : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BIACDU&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 90mg capsules : 30</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BIADDV&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MXL 120mg capsules : 15</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BKAAEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 10mg modified-release capsules : 983</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BKABEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 30mg modified-release capsules : 413</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BKACEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 60mg modified-release capsules : 103</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BKADEB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 100mg modified-release capsules : 50</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BKAEEI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 200mg modified-release capsules : 32</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BNAAAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 10mg tablets : 229</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BNABAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 30mg tablets : 173</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0407020Q0BNACAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphgesic SR 60mg tablets : 14</a></li></ul></td></tr><tr class="row_6">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1001030L0&amp;denomIds=10.1.3&amp;selectedTab=summary">Leflunomide</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_5_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>256</td>
      <td>Rheumatic disease suppressant drugs</td>
      <td>50991</td>
      <td>0.01</td>
      <td>0.05</td>
      <td>0.02</td>
      <td>-2.37</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_Wkf7eE6tnVZta2lRWxGRaikitOAgRxQU"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_Wkf7eE6tnVZta2lRWxGRaikitOAgRxQU" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_5_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1001030L0AAAAAA&amp;denomIds=10.1.3&amp;selectedTab=summary" target="_blank">Leflunomide 10mg tablets : 173</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=1001030L0AAABAB&amp;denomIds=10.1.3&amp;selectedTab=summary" target="_blank">Leflunomide 20mg tablets : 83</a></li></ul></td></tr><tr class="row_7">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0&amp;denomIds=9.6.4&amp;selectedTab=summary">Colecalciferol</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_6_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>578073</td>
      <td>Vitamin D</td>
      <td>610310</td>
      <td>0.95</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-2.36</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_9JQoGKNgCaIirIqCirwYQFcDljFAUHM0"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_9JQoGKNgCaIirIqCirwYQFcDljFAUHM0" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_6_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAACAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,000unit tablets : 489</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAANAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit capsules : 24253</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAARAR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000units/5ml oral suspension : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABFBF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 600unit capsules : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit tablets : 9072</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABHBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit capsules : 3665</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABIBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit capsules : 1114</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABMBM&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral solution : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABNBN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000units/5ml oral solution : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABSBS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g tablets : 5129</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABTBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000units/ml oral drops sugar free : 338</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABUBU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 1.25g chew tab : 2562</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABWBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 12355</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABXBX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 440unit/Calcium carb 1.25g efferv gran sach : 606</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABYBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 43714</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AABZBZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit/Calcium phosphate 3.1g oral pdr sach : 368</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACBCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g efferv tab : 3555</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACCCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g tablets : 235</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACDCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 750mg tablets : 6368</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACHCH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 300,000units/1ml inj ampoules : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACICI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/dose oral spray sugar free : 29</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACJCJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800units/ml oral drops sugar free : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACNCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit tablets : 99</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACPCP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,200unit tablets : 37</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACQCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit tablets : 195</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACRCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit tablets : 1862</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACSCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit tablets : 4930</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACUCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/5ml oral solution : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACVCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 40,000unit capsules : 1771</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACWCW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit / Calcium carbonate 1.25g tablets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AACYCY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADADA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops sugar free : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADBDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit tablets : 618</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADDDD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit orodispersible tablets sugar free : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADFDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,200unit capsules : 432</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADGDG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000units/ml oral solution : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADHDH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000units/1ml soln ud amp sugar free : 514</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADIDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 880unit / Calcium carbonate 2.5g chew tab : 358</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADKDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit tablets : 386</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADLDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit / Calcium carbonate 2.5g chewable tab : 508</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADNDN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral drops sugar free : 126</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADPDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/ml oral solution sugar free : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADQDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,400units/ml oral drops sugar free : 275</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADRDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit capsules : 8428</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADSDS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 15,000units/5ml oral solution : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADTDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,740units/ml oral drops sugar free : 87</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADUDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000units/1ml soln ud amp sugar free : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADVDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit capsules : 214</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADWDW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,200unit capsules : 86</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADXDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,500unit capsules : 98</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADYDY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,000unit capsules : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AADZDZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 30,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAEAEA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,000unit capsules : 68</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAEBEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit / Calcium carbonate 2.5g chew tab : 346</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAECEC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit capsules : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAEEEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit tablets : 44</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAEJEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 5,600unit capsules : 65</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAEKEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit capsules : 135</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAELEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit tablets : 663</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAENEN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 15,000units/5ml oral solution sugar free : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAEPEP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000units/5ml oral solution sugar free : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAEQEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit capsules : 81</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAERER&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit chewable tablets : 42</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAESES&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit chewable tablets : 36</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAETET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/ml oral drops sugar free : 116</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAEVEV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000units/ml oral drops sugar free : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAEWEW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,500unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAFGFG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200units/drop oral drops : 400</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0AAFHFH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000units/drop oral drops sugar free : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BEAADW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 2,200unit capsules : 63</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BEABBF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 600unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BEACBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 1,000unit tablets : 184</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BEADBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 1,000unit capsules : 706</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BEAEBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 400unit capsules : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BEAGED&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Solgar Vitamin D3 1,000unit chewable tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BHAABN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">BabyD 1,000units/ml oral solution : 88</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIAABI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 400unit capsules : 256</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 1,000unit capsules : 1420</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIACDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,500unit capsules : 134</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIADDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 10,000unit capsules : 172</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIAEDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 20,000unit capsules : 459</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIAGBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid drops : 183</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIAICU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid : 198</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIAJAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 800unit capsules : 62</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIAKAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 800unit Vegan capsules : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIALDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 3,200unit Vegan capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIAMDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 20,000unit Vegan capsules : 16</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIANBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml Vegan liquid drops : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BIAPCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml Vegan liquid : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BJABEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Lamberts Vitamin D3 400unit tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BJADBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Lamberts Vitamin D3 1,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BKAABS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 tablets : 72484</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BKABDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 One a Day 1000mg/880unit chewable tablets : 2055</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BMAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit tablets : 5689</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BMABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit capsules : 249</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BNAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 chewable tablets tutti frutti : 35345</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BNABBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Lemon chewable tablets : 6425</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BNACCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 3644</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BNADCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 750mg/200unit caplets : 56416</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BPAABX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Cacit D3 effervescent granules sachets : 548</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BQAABW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calceos 500mg/400unit chewable tablets : 29735</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BRAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 chewable tablets : 5209</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BRABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 Forte chewable tablets : 14848</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BRACCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 500mg/400unit caplets : 170</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BRADDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 1000mg/800unit Once Daily chewable tablets : 557</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BSAABZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calfovit D3 oral powder sachets : 564</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BUAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Natecal D3 600mg/400unit chewable tablets : 263</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit tablets : 889</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWABCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit tablets : 162</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWACCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit tablets : 1083</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWADCY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 50,000unit tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAEDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000unit tablets : 279</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAFCN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 5,000unit tablets : 87</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAGAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,000unit tablets : 80</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAHEP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000units/ml oral solution : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAIBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000units/ml oral drops : 66</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAJEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit tablets : 93</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAKCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit tablets : 312</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWALBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit capsules : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAMDW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,200unit capsules : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWANDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,200unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAPDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit capsules : 31</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAREN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 15,000units/5ml oral solution : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWASEN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,000units/ml oral solution : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAUAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 800unit capsules : 265</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAVDX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,500unit capsules : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAWDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 25,000unit tablets : 45</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAYEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit Vegan tablets : 15</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWAZBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit Vegan tablets : 53</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWBABH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit capsules : 268</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BWBBDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit capsules : 168</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BXAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 800unit capsules : 65055</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BXABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 3,200unit capsules : 1369</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BXACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 20,000unit capsules : 17101</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BXADDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 2,740units/ml oral drops : 204</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BXAEDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium daily D3 2,740units/ml drops : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0BZAACI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">DLux 400 oral spray : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CCAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 forte 3,000units/ml liquid : 181</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CEAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 800unit capsules : 172</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CEABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 1,000unit capsules : 68</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CEACEA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 5,000unit capsules : 12</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CEADDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Bio-Vitamin D3 20,000unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CGAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 20,000unit capsules : 12116</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CGABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 3,200unit capsules : 70</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CHAAEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 400unit tablets : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CHABBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 1,000unit tablets : 24</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CHADAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000unit tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CHAECN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 5,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CHAFCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 10,000unit tablets : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CHAIEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 50,000unit capsules : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CHAJDS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 3,000units/ml liquid : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CHAKCU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 2,000units/ml liquid : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CJAACS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 800unit tablets : 5033</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CJABEE&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 4,000unit tablets : 26</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CKABBF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Cubicole D3 600unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CNACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Plenachol D3 20,000unit capsules : 1047</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CNADCV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Plenachol D3 40,000unit capsules : 734</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CVAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 20,000unit capsules : 1009</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CVABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">OsteoCaps D3 1,000unit capsules : 602</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CWAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Evacal D3 1500mg/400unit chewable tablets : 29072</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CYAADA&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">HealthAid Vitamin D3 200units/drop oral drops : 32</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0CYACBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">HealthAid Vitamin D3 1,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DBAACN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 High Strength 5,000unit tablets : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DCABDD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 Lemon Melts 2,000unit tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DDAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Kora LiquiD 3000units/ml oral solution : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DFAADH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000units/1ml oral solution : 7326</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DFABDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 2,400units/ml oral drops : 855</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DFACDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000units/1ml oral solution : 89</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DFADAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 800unit capsules : 4140</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DFAEBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 400unit capsules : 84</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DFAFEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000unit capsules : 362</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DFAGEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000unit capsules : 235</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DFAHEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 5,600unit capsules : 114</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DGAADI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">TheiCal-D3 1000mg/880unit chewable tablets : 530</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DHAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 1,000unit tablets : 12605</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DHABDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 25,000unit tablets : 19454</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DIAADN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 10,000units/ml oral drops : 288</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DIABDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 25,000units/2.5ml oral solution : 144</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DKAFET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Vitamin D3 400units/ml for infants and children dps : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DMAAEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calci-D 1000mg/1,000unit chewable tablets : 17369</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DNAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 800unit capsules : 460</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DNABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 3,200unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DNACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 20,000unit capsules : 460</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DPAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 800unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DPAFBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 400unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DPAGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeKal-D3 1,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DXAAES&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Urgent-D 2,000unit chewable tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DZAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 200unit with Calcium 500mg chewable tablets : 50</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0DZABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 400unit with Calcium 500mg chewable tablets : 53</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0ECAKCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 20,000unit tablets : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0906040G0ECAMDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">ColeDose D3 20,000unit capsules : 6</a></li></ul></td></tr><tr class="row_8">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0&amp;denomIds=1.1.2&amp;selectedTab=summary">Alginic acid compound preparations</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_7_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>57448</td>
      <td>Compound Alginates and proprietary indigestion preparations</td>
      <td>57921</td>
      <td>0.99</td>
      <td>1.00</td>
      <td>0.00</td>
      <td>-2.35</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_Gpe6vdCISoISIjCBYixvgAimqiJAWUc"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_Gpe6vdCISoISIjCBYixvgAimqiJAWUc" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_7_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0AAAHAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Alginate raft-forming oral suspension sugar free : 1069</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0AAAJAJ&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sod algin 225mg/Mag algin 87.5mg/dose oral pdr sach SF : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0AAALAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg/5ml susp SF : 6414</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0AAAPAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg chew tab SF : 854</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEABAG&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon 500mg chewable tablets peppermint : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEACAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Original Aniseed Relief : 660</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEADAJ&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Infant oral powder sachets : 3498</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEAFAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Peppermint Liquid Relief : 414</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEAIAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral suspension aniseed (Reckitt Benckiser) : 7289</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEAJAM&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Liquid 10ml sachets : 43</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEANAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Cool Liquid : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEAQAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance Mint chewable tablets (Reckitt Benckiser) : 2613</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEARA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action chewable tablets mint : 652</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEASA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action Liquid peppermint : 405</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEAUAR&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Peppermint chewable tablets : 250</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEAVA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action Liquid aniseed : 149</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEAWAR&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Strawberry chewable tablets : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEBDA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action Liquid 10ml sachets : 33</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEBEAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral susp peppermint (Reckitt Benckiser) : 9263</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BEBFA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action chewable tablets mixed berries : 19</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BIAAAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Peptac liquid aniseed : 7623</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BIABAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Peptac liquid peppermint : 15257</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BQAAAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Acidex oral suspension aniseed : 47</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BQABAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Acidex oral suspension peppermint : 53</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BQACAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Acidex Advance oral suspension aniseed : 311</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0101021B0BQADAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Acidex Advance oral suspension peppermint : 476</a></li></ul></td></tr><tr class="row_9">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0&amp;denomIds=5.3.2&amp;selectedTab=summary">Aciclovir</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_8_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>16808</td>
      <td>Herpes simplex and varicella-zoster</td>
      <td>18582</td>
      <td>0.90</td>
      <td>0.95</td>
      <td>0.02</td>
      <td>-2.17</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_DY8ad0rFBQUZGdwFBBEZsRCQwX0YcAUk"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_DY8ad0rFBQUZGdwFBBEZsRCQwX0YcAUk" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_8_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0AAAAAA&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg/5ml oral suspension sugar free : 106</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0AAABAB&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg tablets : 4911</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0AAACAC&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg tablets : 7469</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0AAADAD&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg tablets : 3108</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0AAAEAE&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg dispersible tablets : 236</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0AAAFAF&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg/5ml oral suspension sugar free : 30</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0AAAGAG&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg dispersible tablets : 613</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0AAAHAH&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg dispersible tablets : 322</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0BBAEAE&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Zovirax 800mg dispersible tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0503021C0BBAGAG&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Zovirax 200mg dispersible tablets : 10</a></li></ul></td></tr><tr class="row_10">
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0&amp;denomIds=4.9.1&amp;selectedTab=summary">Ropinirole hydrochloride</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_9_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>5890</td>
      <td>Dopaminergic drugs used in parkinsonism</td>
      <td>69666</td>
      <td>0.08</td>
      <td>0.16</td>
      <td>0.04</td>
      <td>-2.12</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_y9HR44JTijMoIwweQUVBR5agkAIJCFFA"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_y9HR44JTijMoIwweQUVBR5agkAIJCFFA" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_9_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAAAAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 250microgram tablets : 713</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAABAB&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 1mg tablets : 793</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAACAC&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 2mg tablets : 763</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAADAD&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 5mg tablets : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAAHAH&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 500microgram tablets : 706</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAAKAK&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 2mg modified-release tablets : 510</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAALAL&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 4mg modified-release tablets : 308</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAAMAM&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 8mg modified-release tablets : 178</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAARAR&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 3mg modified-release tablets : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0AAASAS&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropinirole 6mg modified-release tablets : 146</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BBAAAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">ReQuip 250microgram tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BBABAB&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">ReQuip 1mg tablets : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BBACAC&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">ReQuip 2mg tablets : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BBADAD&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">ReQuip 5mg tablets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BBAGAK&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">ReQuip XL 2mg tablets : 39</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BBAHAL&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">ReQuip XL 4mg tablets : 118</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BBAIAM&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">ReQuip XL 8mg tablets : 87</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BCAAAH&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Adartrel 500microgram tablets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BCABAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Adartrel 250microgram tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BDAAAK&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Spiroco XL 2mg tablets : 295</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BDABAL&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Spiroco XL 4mg tablets : 110</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BDACAM&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Spiroco XL 8mg tablets : 227</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BFAAAL&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Repinex XL 4mg tablets : 146</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BFABAM&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Repinex XL 8mg tablets : 96</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BFACAK&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Repinex XL 2mg tablets : 145</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BGAAAK&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Raponer XL 2mg tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BIAAAK&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ipinnia XL 2mg tablets : 81</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BIACAL&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ipinnia XL 4mg tablets : 237</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BIADAS&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ipinnia XL 6mg tablets : 25</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BIAEAM&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ipinnia XL 8mg tablets : 75</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BKAAAK&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropiqual XL 2mg tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=W2U3Z&amp;numIds=0409010H0BKABAL&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Ropiqual XL 4mg tablets : 2</a></li></ul></td></tr></tbody></table>
            </div>
        </div>
    </section>

    <script crossorigin="anonymous" integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg==" referrerpolicy="no-referrer" src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"></script>
    <script>
        var tooltipTriggerList = [].slice.call(
            document.querySelectorAll('[data-bs-toggle="tooltip"]')
        );
        var tooltipList = tooltipTriggerList.map(function(tooltipTriggerEl) {
            return new bootstrap.Tooltip(tooltipTriggerEl);
        });
    </script>

    <script>
        ["higherHeading-lowShowHide", "lowerHeading-lowShowHide"].forEach(function(
            btn
        ) {
            var toggleButton = document.getElementById(btn);
            var section = toggleButton.closest("section");
            toggleButton.addEventListener("click", function(e) {
                var lowRows = section.querySelectorAll("tr.low_number");
                lowRows.forEach(function(row) {
                    return row.classList.toggle("d-none");
                });

                if (toggleButton.textContent === "Hide low numbers") {
                    toggleButton.textContent = "Show low numbers";
                    toggleButton.classList.remove("btn-outline-danger");
                    toggleButton.classList.add("btn-outline-success");
                } else {
                    toggleButton.textContent = "Hide low numbers";
                    toggleButton.classList.remove("btn-outline-success");
                    toggleButton.classList.add("btn-outline-danger");
                }
            });
        });
    </script>

    <script>
        var explainerTextCollapse = document.getElementById("explainerTextCollapse");
        var explainerTextBtn = document.getElementById("explainerTextBtn");
        explainerTextCollapse.addEventListener("hidden.bs.collapse", function() {
            explainerTextBtn.textContent = "Show more +";
        });
        explainerTextCollapse.addEventListener("shown.bs.collapse", function() {
            explainerTextBtn.textContent = "Show less -";
        });
    </script>
</body>

</html>